Stocktoria
Siemens Healthineers AG SHL.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Siemens Healthineers AG financials (annual)
Bars are annual figures from 2021 to 2024; red bars are negative (a loss or cash outflow).
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | €22.4B | €21.7B | €21.7B | €18.0B |
| Gross profit | €8.5B | €7.7B | €8.1B | €7.0B |
| R&D expense | €1.9B | €1.9B | €1.8B | €1.5B |
| SG&A expense | €3.7B | €3.6B | €3.4B | €2.8B |
| Operating income | €2.8B | €2.1B | €2.9B | €2.6B |
| Interest expense | €476.0M | €296.0M | €118.0M | €83.0M |
| Income tax | €564.0M | €403.0M | €746.0M | €658.0M |
| Net income | €1.9B | €1.5B | €2.0B | €1.7B |
| EPS (diluted) | €1.73 | €1.34 | €1.81 | — |
| Operating cash flow | €2.8B | €2.1B | €2.5B | €2.9B |
| Free cash flow | €2.1B | €1.3B | €1.7B | €2.3B |
| Cash & equivalents | €2.7B | €2.2B | €1.4B | €1.3B |
| Inventory | €4.1B | €4.3B | €4.0B | — |
| Goodwill | €17.7B | €18.1B | €19.1B | — |
| Total assets | €46.1B | €46.7B | €49.1B | €42.2B |
| Total debt | €780.0M | €633.0M | €694.0M | — |
| Total liabilities | €27.8B | €28.6B | €29.2B | €25.8B |
| Shareholders' equity | €18.2B | €18.1B | €19.8B | €16.3B |
| Share buybacks | €0 | €421.0M | €309.0M | €255.0M |
Growth · year-over-year · Revenue CAGR 7.5%
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue growth | +3.2% | -0.2% | +20.7% | — |
| Net income growth | +28.7% | -26.0% | +18.0% | — |
| EPS growth | +29.1% | -26.0% | — | — |
| Free cash flow growth | +66.3% | -22.5% | -26.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · DE · as of 2024-09-30. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.